<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>j health sci med / jhsm</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Journal of Health Sciences and Medicine</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">2636-8579</issn>
                                                                                            <publisher>
                    <publisher-name>MediHealth Academy Yayıncılık</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.32322/jhsm.668754</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Health Care Administration</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Sağlık Kurumları Yönetimi</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <trans-title-group xml:lang="tr">
                                    <trans-title>Kırk yaş üzeri tip 2 diabetes mellituslu hastalarda ayak bileği kol indeksinin periferik arter hastalığını saptamadaki değeri ve periferik arter hastalığının diyabetin kronik komplikasyonları ile ilişkisi</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>The significance of ankle-brachial index in determining peripheral artery disease in patients with type 2 diabetes mellitus over 40 years of age and the relationship of peripheral artery disease with chronic complications of diabetes</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0001-9962-8882</contrib-id>
                                                                <name>
                                    <surname>Yiğenoğlu</surname>
                                    <given-names>Tuğçe Nur</given-names>
                                </name>
                                                                    <aff>Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Hematoloji ve Kemik İliği Nakil Ünitesi</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-8286-5256</contrib-id>
                                                                <name>
                                    <surname>Kebapçı</surname>
                                    <given-names>Medine</given-names>
                                </name>
                                                                    <aff>Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Hastanesi Endokrinoloji Bilim Dalı</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-4144-3732</contrib-id>
                                                                <name>
                                    <surname>Özen</surname>
                                    <given-names>Hülya</given-names>
                                </name>
                                                                    <aff>Eskisehir Osmangazi University, Biostatistic Department, Eskişehir</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20200319">
                    <day>03</day>
                    <month>19</month>
                    <year>2020</year>
                </pub-date>
                                        <volume>3</volume>
                                        <issue>2</issue>
                                        <fpage>115</fpage>
                                        <lpage>120</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20200101">
                        <day>01</day>
                        <month>01</month>
                        <year>2020</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20200210">
                        <day>02</day>
                        <month>10</month>
                        <year>2020</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2018, Journal of Health Sciences and Medicine</copyright-statement>
                    <copyright-year>2018</copyright-year>
                    <copyright-holder>Journal of Health Sciences and Medicine</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="tr">
                            <p>Giriş: Periferik arter hastalığı (PAH); serebrovasküler vekardiyovasküler hastalıklarda mortalite ve morbiditenin önemli birprediktörüdür. Diyabetik ve diyabetik olmayan hastalar karşılaştırıldığındadiyabetik hastalarda PAH insidansının 2 ila 4 kat daha fazla olduğu bildirilmiştir.ayak bileği-kol indeksi (ABI), PAH tanısında kullanılan kolay uygulanabilir biryöntemdir. Çalışmamızda merkezimizde takip edilen 40 yaş üzeri tip 2 diabetes mellitus(DM) hastalarında ABI ile PAH prevalansını saptamak, alt ekstremite arteryeldoppler ultrasonografi(USG) bulgularıyla kıyaslamak ve tip 2 DM’nin kronikkomplikasyonları ile PAH arasındaki ilişkileri ortaya koymak amaçlanmıştır. Gereç ve Yöntem: Çalışmaya 40 yaş üzeri 111 tip 2 DM hastasıalındı. ABI; her iki ayak bileği seviyesinden alınan sistolik kanbasınçlarından (SKB) daha BÜYÜK olanının, her 2 koldan ölçülen SKB’larındandaha büyük olanına bölünmesiyle hesaplandı ve &quot;ABI-1&quot; olaraktanımlandı. Her iki ayak bileği seviyesinden alınan SKB’larından daha DÜŞÜKolanının, her iki koldan ölçülen SKB’larından daha büyük olanına bölünmesi ilede ABI-2 hesaplandı. Daha sonra her iki yöntemle de hesaplanan ABI değerleri,aralık değerlerine göre üç gruba ayrıldı. Grup 1’de 0,9 ve altı ABI değerleri,Grup 2’de 0,9 ve 1,30 arası dışındaki, Grup 3’te 0,9 ve 1,40 arası dışındaki değerler PAH lehine yorumlandı (Tablo).Arada boşlukBulgular: Kırk yaş üzeri diyabetik hastalarda PAH prevalansı %19,8olarak bulundu. PAH’ı saptamada en spesifik ABI-2G1 grubu, en sensitif iseABI-1G2 ve ABI-2G2 grupları oldu. PAH ile klopidogrel kullanımı, azalmışvibrasyon hissi, yaş, DM süresi, insülin direnci, glomerüler filtrasyon hızı,albuminüri, homosistein ve ürik asit düzeyleri arasında anlamlı bir ilişkibulundu.Sonuç: ABI, DM hastalarında PAH tanısı için sensitif bir yöntemdir.Çalışmamızın diğer çalışmalara göre üstün tarafı ABI’nın her iki yöntemle dehesaplanması ve ABI değerlerinin kesim noktalarına göre üçer gruba ( ≤0,9 ;≤0,9 - &amp;gt;1,30 ; ≤0,9 - &amp;gt;1,40) ayrılmasıdır. Diyabetik hastalarda PAH tanısınıkoymak için ABI’nın özellikle ikinci hesaplama yöntemiyle (ABI-2) değerlendirilmesi, gelecekte oluşmasıbeklenen komplikasyonların önüne geçilmesi açısından önem taşır.</p></trans-abstract>
                                                                                                                                    <abstract><p>Introduction: Peripheral artery disease(PAD) acts as an important predictor of mortality and morbidity incerebrovascular and cardiovascular diseases. The incidence of PAD was reportedto be 2 to 4 times higher in diabetic patients compared with non-diabeticpatients. Ankle brachial index (ABI) isan easily applicable method for the diagnosis of PAD. The aim of this study isto determine the prevalence of PAD by using ABI in patients with Type 2Diabetes Mellitus (DM) over 40 years of age, compare the results with lowerextremity arterial Doppler ultrasonography (USG) and to reveal the relationshipbetween chronic complications of DM and PAD. Material and Method: The study included111 DM patients over 40 years of age. ABI; was calculated by dividing thehigher systolic blood pressures (SBP) taken from both ankle levels to thehigher SBPs measured in both arms and defined as &quot;ABI-1&quot;. ABI-2 wascalculated by dividing the lower SBPs taken from both ankle levels to thehigher SBPs measured from both arms. ABI values ​​calculated by both methodswere divided into 3 groups according to cut off values. ABI values ​​of 0.9 andless in Group 1, ​​between 0.9 and 1.30 in Group 2, ​​between 0.9 and 1.40 inGroup 3 were interpreted in favor of PAD. Results: The prevalence of PAD was19.8%. The most specific group for detecting PAD was ABI-2G1, and the mostsensitive groups were ABI-1G2 and ABI-2G2. A significant relationship was foundbetween PAD and clopidogrel use, decreased vibration sensation, age, durationof DM, insulin resistance, glomerular filtration rate, albuminuria,homocysteine ​​and uric acid levels. Conclusion: ABI is a sensitive methodfor detecting PAD. Thesuperior side of our study compared to the other studies is that the ABI iscalculated by 2 methods and ABI values are divided into 3 groups according tocut off values (≤0,9 ; ≤0,9 - &amp;gt;1,30 ; ≤0,9 - &amp;gt;1,40).</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Peripheral artery disease</kwd>
                                                    <kwd>  diabetes mellitus</kwd>
                                                    <kwd>  ankle-brachial index</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="tr">
                                                    <kwd>Periferik arter hastalığı</kwd>
                                                    <kwd>  diabetes mellitus</kwd>
                                                    <kwd>  ayak bileği-kol indeksi</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">REFERENCES</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">1- Türkiye Endokrinoloji ve Metabolizma Derneği DM ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu 2019</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">2- Ronald A. Codario. Çeviri: Karşıdağ K, Sağlam H.Tip 2 Diyabet, Pre-Diyabet ve Metabolik Sendrom: Birinci Basamak Tanı ve Tedavi Rehberi- Bölüm 8. Humana Press 2005</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">3- Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">4- Oser RF, Picus D, Hicks ME, et al. Accuracy of DSA in the evaluation of patency of infrapop¬liteal vessels. J Vasc Interv Radiol 1995; 6: n589–594</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">5- Sorensen KE, Kristensen IB, Celermajer DS. Atherosclerosis in the human mbrachial artery. J Am Coll Cardiol 1997; 29: 318–322.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">6- Welten GM, Schouten O, Chonchol M, et al. Prognosis of patients with peripheral arterial disease. J Cardiovasc Surg (Torino)2009;50:109-21.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">7- Matthews DR, Hosker JP, Rudenski AS, et al. &quot;Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (7): 412–9.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">8- Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006;47:921-9.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">9-Chou CK, Weng SW, Chang HW, et al. Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan. Diabetes Res Clin Pract 2008; 81: 331-337.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">10-Thomas GN, Critchley JA, Tomlinson B, et al. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003; 20: 988-995</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">11-Tseng CH. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003; 54: 331-338.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">12- Criqui MH, Fronek A, Klauber MR, et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985; 71:516–522</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">13- Wang Li, Du Fan, MAO Hong, et al. Prevalence and related risk factors of peripheral arterial disease in elderly patients with type 2 diabetes in Wuhan, Central China</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">14- Yu J, Hwang J, Shin M, et al.  The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital; Diabetes Metab 2011; n35:543 -550</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">15-Schroder F, Diehm N, Kareem S, et al. A modified calcula¬tion of ankle–brachial npressure index is far more sensitive in the detection of peripheral arterial ndisease. J Vasc Surg 2006; 44: 531–536.</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">16- Niazi K, Khan TH, Easley KA. Diagnostic utility of the two methods of ankle  brachial index in the detection of peripheral arterial disease of lower nextremities. Catheter Cardiovasc Interv 2006; 68: 788–792.</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">17- Klein S, Hage JJ. Measurement, calculation, and normal range of the ankle–arm nindex: a bibliometric analysis and recommendation for standardization. Ann Vasc Surg 2006; 20: 282–292.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">18- Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208.</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">19- Price JF, Stewart MC, Douglas AF, et al.  Frequency of a low ankle brachial index in the general population by age, sex and deprivation: cross-sectional survey of 28,980 men and women. Eur J Cardiovasc Prev Rehabil 2008, 15(3):370-5.</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">20- Monteiro R, Marto R, Neves M. Risk Factors Related to Low Ankle-Brachial Index Measured by Traditional and Modified Definition in Hypertensive Elderly Patients</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">21-Al-Delaimy WK, Merchant TA, Rimm EB, et al. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116(4):236-240.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">22- Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated nhemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. n2004;141(6):421-431.</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">23- Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006 Aug;17(8):2100- 2105. Epub 2006 Jul 6</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">24- Adler A, Stevens R, Neil A.  UKPDS 59: Hyperglycemia and Other Potentially Modiﬁable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">25-M. Langlois, D. De Bacquer, D. Duprez, et al. “Serum uric acid in hypertensive patients with and without peripheral narterial disease,”Atherosclerosis, vol. 168, no. 1, pp. 163–168, 2003</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">26- Jorge Escobedo J, S. Rana, Lombardero M, et al.Association Between Albuminuria and Duration of Diabetes and Myocardial Dysfunction and Peripheral Arterial Disease Among Patients With Stable Coronary Artery Disease in the BARI 2D Study</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">27- Uzun Ş, Vural H, Uzun M, et al. Koroner kalp hastalığı ciddiyetinin tahmininde kolay bir fiziksel değerlendirme bulgusu olan ayak bileği-kol indeksinin kullanılması, Gülhane Tıp Dergisi 2005; 47: 279-281.</mixed-citation>
                    </ref>
                                    <ref id="ref29">
                        <label>29</label>
                        <mixed-citation publication-type="journal">28- Heald CL, Fowkes FG, Murray GD, Price JF; Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the nankle-brachial index: Systematic review. Atherosclerosis 2006; 189:61–69.</mixed-citation>
                    </ref>
                                    <ref id="ref30">
                        <label>30</label>
                        <mixed-citation publication-type="journal">29-Filippella M, Lillaz E, Ciccarelli A, et al. Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patients. J Endocrinol Invest 2007, 30:721-725.</mixed-citation>
                    </ref>
                                    <ref id="ref31">
                        <label>31</label>
                        <mixed-citation publication-type="journal">30-Onufrak SJ, Bellasi A, Shaw LJ, et al. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis. 2008;199(2):424–431.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
